
Viseon completed an insider financing round. Funds will enable further 4K-ADV product development and market expansion focusing on several fronts where digitization of open and minimally invasive surgery can facilitate clinical and economic benefits. Deployment and adoption of Viseon technology continues expansion in the spine market, with 2024 Year to Date growth up more than 22% compared to the same period in 2023.
Pete Davis, Viseon’s President and Chief Operating Officer, stated, “We continue to hear that better visualization with our MaxView 4K technology equates to increased safety, better training, better ergonomics and improved workflow, improving overall OR efficiency. We continue refining resource management to streamline our investment priorities and broadening the applications for our newer technologies.”
Source: Viseon, Inc.
Viseon completed an insider financing round. Funds will enable further 4K-ADV product development and market expansion focusing on several fronts where digitization of open and minimally invasive surgery can facilitate clinical and economic benefits. Deployment and adoption of Viseon technology continues expansion in the spine market, with...
Viseon completed an insider financing round. Funds will enable further 4K-ADV product development and market expansion focusing on several fronts where digitization of open and minimally invasive surgery can facilitate clinical and economic benefits. Deployment and adoption of Viseon technology continues expansion in the spine market, with 2024 Year to Date growth up more than 22% compared to the same period in 2023.
Pete Davis, Viseon’s President and Chief Operating Officer, stated, “We continue to hear that better visualization with our MaxView 4K technology equates to increased safety, better training, better ergonomics and improved workflow, improving overall OR efficiency. We continue refining resource management to streamline our investment priorities and broadening the applications for our newer technologies.”
Source: Viseon, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.